JT_AR14J_p001-p075_0410.indd

Similar documents
annual.fy2015_J_partition02

annual.fy2016_J_partition02

アニュアルレポート2013 -Operation & Analysis-

アニュアルレポート 2013年度

アニュアルレポート2013

アニュアルレポート Operation & Contribution -

Financial Information (P )

Annual Report 財務情報-

JT_AR14J_p001-p075_0417_下.indd

JT M-vol.4

At a Glance 当社グループの事業について 2015 年度 2015 年 12 月 31 日終了年度 当社グループは 70 以上の国と地域で事業を展開するグローバルたばこメーカーです 我々の製品は120 以上の国と 地域で販売されており Winston Camel MEVIUSやLDといった

2017年度 決算補足資料(データ集)

JT International 2009年海外たばこ事業実績(速報) (unaudited)

JTI 2014年実績及び2015年業績予想

JTI Investor Relations Presentation FY Tokyo, February 7, 2012

JTI Presentation2008

JT M-vol.2

2016年 海外たばこ事業実績

2011年 海外たばこ販売実績資料

2017年12月期 第3四半期 JTI業績報告資料

JT医薬事業における研究開発

海外たばこ事業実績補足資料(2015 年1-3 月期)

Corporate Philosophy Otsuka-people creating new products for better health worldwide

Contributes to The Health of Individuals Worldwide

2017年度 JTI業績報告資料

untitled

Our Credo Top Message Japan Europe Asia America 1 CORPORATE BOOK 2011 CORPORATE BOOK

Corporate Social Responsibility Report Contents 2 3

アニュアルレポート 財務ハイライト-

2017年度 決算説明会資料(CFOプレゼンテーション)

untitled

海外たばこ事業実績補足資料2015年1-12月期及び10-12月期

Lixil_H1-4_13_PDF.indd

名大_医学部保健学科年報第8巻/巻頭

OVERVIEW Our Sustainability ALSOK 1 ALSOK 1 P P.12 3 P.26 4 ALSOK 8 P.9

2014度事業報告書p000_018.indd

Otsuka-people creating new products for better health worldwide Contents

アニュアルレポート2017

fiú

advantest_cr.indd

キヤノンマーケティングジャパングループ CSR報告書 情報セキュリティ報告書

-February FRB BIS IMF BIS Spillover Spillovers BIS IMF EMEs

アニュアルレポート 2014

18年度石見美術館年報最終.indd

C O N T E N T S Annual Report

3131_2014_02.pdf

...j.N.. AR2005(.O..)

2014CSR.pdf

大和ハウスグループ アニュアルレポート2006

2018年12月期第2四半期 決算レポート

2017年12月期 第3四半期 決算説明会資料

2015 KV KV2015 KV2015 KV2015 KV KIRIN 2

ニコンレポート2016

アニュアルレポート 2013

untitled

HIV STD

Q A Q A 1

NIKON REPORT2018

H1-4_0603no.ai

日赤やまびこ7号_1P

日赤やまびこ9号_1P


中国市場における日系・欧米系企業の戦略比較

2018年12月期 第3四半期 決算レポート

日立 統合報告書 2017 (2017年3月期)


Sysmex_Report_2017

untitled

Kyoto Sangyo University Slywotzky and Morrison 1997 Slywotzky ,2001, ,550 6, ,87

RIETI Highlight VOL.25

ニコンレポート2017

design.indd

スライド タイトルなし

アニュアルレポート 2000

研究レポート表紙.PDF


J_ANA_ar11納品PDF用 indd

maiji2007_cover_j_0907


ITC saiban/dai8/siryou.pdf 4 :PROLEG : AI 1

untitled

aishin00_100608

MISUMI It s about TIME QCT 8 12 CSR

橡食品班論文[1].PDF

76 1 2

09[ ]鶴岡(責).indd

ワールド・ワイド 6‐1◆/3.亀田=

アニュアルレポート2018

NBO_AR J_c1-p22

Industrial automation and control business PAGE 16 Test and measurement business PAGE 18 New and other businesses PAGE 20 Conten

1) IT IR CSR 120 DAIWA SECURITIES GROUP ANNUAL REPORT 2010

M&A / & 18 &

Channel to Discovery Plan &

CONTENTS N T

_JTEKT 2015 AR 日本語版H1.4

MSD Human Resources Global Compliance Organization Office of Ethics Global Safety and the EnvironmentGlobal Compliance Organization Office of Ethics O

7,447 1,384 1,62 6,886 1,474 1,79 23, 4,3 3,2 62% 66% 67% 14,334 2,859 2,142 1

Vision and Strategy IP 1 Fields: An Evolving History Performance At a Glance Sustainability CSR Financial Sect

日本軽金属株式会社

66期_00丁付出稿用.indd

Transcription:

Factory floor of Kansai factory: One of the key tobacco manufacturing plants in Japan

022 026 045 JT 046 050 OPERATIONS & ANALYSIS JT

Industry Overview Electronic Cigarette e-cigarette Vapor E-VaporHeat-not-Burn e-cigarette E-Vapor 5.7 40% 2013 * 2014 * * EU 2017 5 JT 42/3 * M&A * Euromonitor e-cigarette2014 022 JAPAN TOBACCO INC. ANNUAL REPORT 2014

10 2010 2011 2012 2013 2014 23,167 24,062 24,616 24,905 25,429 3,831 3,751 3,708 3,463 3,165 3,091 3,006 2,927 2,795 2,702 1,816 1,918 2,031 2,212 2,389 2,179 1,959 1,974 1,941 1,875 986 1,028 1,021 1,009 959 934 912 953 917 947 OPERATIONS & ANALYSIS 905 899 893 885 895 1,014 974 1,025 867 827 839 845 834 796 804 Euromonitor 4 % 2010 2011 2012 2013 2014 Philip Morris International Inc. 24.6 25.1 25.7 25.7 26.2 British American Tobacco Plc. 18.7 19.1 19.0 19.1 19.2 Japan Tobacco Inc. 16.3 15.6 16.0 16.3 16.0 Imperial Tobacco Group Plc. 8.7 8.6 8.5 8.5 8.5 Euromonitor Excluding China National Tobacco Corp (CNTC) 10 2010 2011 2012 2013 2014 Marlboro Philip Morris International Inc. Altria Group Inc. 4,144 4,108 4,141 3,959 3,914 Winston Japan Tobacco Inc. Reynolds American Inc. 1,224 1,224 1,302 1,359 1,279 Pall Mall British American Tobacco Plc. Reynolds American Inc. 994 1,010 1,016 1,048 1,091 L&M Philip Morris International Inc. 847 873 881 895 890 MEVIUS Japan Tobacco Inc. 952 812 844 837 791 Camel Japan Tobacco Inc. Reynolds American Inc. 643 606 603 608 662 Gudang Garam Gudang Garam Tbk PT. 523 537 578 605 643 Kent British American Tobacco Plc. 570 602 636 618 602 Gold Flake ITC Ltd. British American Tobacco Plc. 592 590 619 606 529 Dunhill British American Tobacco Plc. 480 471 470 515 528 Euromonitor Excluding China National Tobacco Corp (CNTC) JAPAN TOBACCO INC. ANNUAL REPORT 2014 023

Industry Overview continued 2013 9,800 2014 IMS Health 2013 36.8% 29.2% 10,000 9.6% 24.4% 2014 IMS Health 8,000 6,000 4,000 2,000 8,306 8,913 9,652 9,573 9,801 21 2014 4 5.6% 0 2009 2010 2011 2012 2013 2014 IMS Health 37% 29% 10% 2014 IMS Health 024 JAPAN TOBACCO INC. ANNUAL REPORT 2014

OPERATIONS & ANALYSIS 2013 8.7%9,771 10,000 8,000 2014 4 5%8% 2013 21.4% 15.8% 12.6% 10.8% 8.0% 31.4% 6,000 4,000 8,327 8,328 8,593 8,992 9,771 2,000 0 2009 2010 2011 2012 2013 JAPAN TOBACCO INC. ANNUAL REPORT 2014 025

Review of Operations R&D Emerging Product 026 JAPAN TOBACCO INC. ANNUAL REPORT 2014

OPERATIONS & ANALYSIS GFB JAPAN TOBACCO INC. ANNUAL REPORT 2014 027

Review of Operations continued 2014 1 12 Thomas A. McCoy President & CEO, JTI 2014JTI 13.1% JTI JTI GFB Fine Cut GFBAmber Leaf Old Holborn JTITop Employer Global 2015 e-cigarette E-LitesZanderaEmerging Product 3,980 4.7% 2,622 2.0% GFB 11,911 3.0% JT JTI90 120JTI JTI JTI +3.5% US 4,253 +1.1% US JT +13.1% Fine Cut11.1% 4.7%3,980 GFB 20% 2015 GFB Emerging Product 2015 8%JTI JT 028 JAPAN TOBACCO INC. ANNUAL REPORT 2014 JTI GFB 958 3.5% 3.0%

Global Flagship Brands (GFB) Portfolio GFBJTI 8GFB Winston 1,296 Global Sales 1954Winston JTI 2007 2100 Camel 464 Global Sales 1913 Camel 85 JTI OPERATIONS & ANALYSIS 5 2014Winston 0.4ppt9.6% No. 2 Winston 2014Camel 0.5ppt 27 3.6% 2014 5 Camel 4 No. 1 5ppt7.9% 30 21 26 10 Fine Cut Camel Black & White 34.1% Essential Activate Fine Cut 2 Winston Core No. 1 Fine Cut Winston XSWinston 1999JTI Camel2014 Winston Core Winston King Size, Winston Super Slims Winston Fine Cut Camel 464 XS Winston 303 Filter King Size 1Fat Slim 2 1999 2014 JT JAPAN TOBACCO INC. ANNUAL REPORT 2014 029

Review of Operations continued 20% 13.1% 1.1% South & West Europe North & Central Europe CIS+ Rest-ofthe-World Total JTI 598 516 1,657 1,208 3,980 GFB 514 278 1,157 672 2,622 US 4,206 2013 reported -423 Volume GFB 2014GFB 2%2,622 GFB 12 0.5ppt 14.3% GFB 1.8ppt 65.9% GFB GFB 0.6ppt 14.4% +13.1% +1.1% 938 Price/ Mix 36 Other 30% 29% 42% 34% 4,757 2014 at constant FX 17% 43% 13% 20% 25% 15% 17% 16% -504 FX 4,253 2014 reported Rest-of-the-World CIS+ North & Central Europe South & West Europe South & West Europe 2014 2013 2.2% GFB 2.1% GFB 1.0% Fine Cut7.1% Winston Camel 0.8ppt 20.8% Benson & Hedges 28.6% Fine Cut GFB 8.3% JTI 2015 Winston Camel Benson & Hedges 0.6% GFB 4.9% Fine Cut WinstonCamel 2.2% 0.7ppt21.7% South & West Europe 5.1% 10.3% 030 JAPAN TOBACCO INC. ANNUAL REPORT 2014

MEVIUS 178 Global Sales 1977 Mild Seven MEVIUS 1 18 LD 449 Global Sales 1999 LD OPERATIONS & ANALYSIS MEVIUS 2007LD JTI 42 Fine Cut 2014 MEVIUS 178 2014 LD 0.1ppt2.4% 449 MEVIUS Fine Cut 7.3% No. 1 0.4ppt5.9% Benson & Hedges Glamour 109 1873Benson & Hedges 72 2005 GlamourJTI Global Sales 2014North & Central Europe Global Sales 2014 Glamour Benson & Hedges 72 109 0.1ppt1.0% 0.1ppt1.9% Silk Cut Sobranie 29 Global Sales 1964 Silk Cut 1970 26 Global Sales Sobranie 1879 2014 2014 Sobranie15.1%26 Silk Cut 29 0.1ppt 0.6% JT JAPAN TOBACCO INC. ANNUAL REPORT 2014 031

Review of Operations continued North & Central Europe 2014North & Central Europe 0.8% GFB 5.4% CIS 8.5% 31.5% Winston Camel Benson & Hedges GFB 5.6% 2.0% 0.2ppt32.0% 40% Sterling Fine CutAmber Leaf No. 1Amber Leaf No. 1 North & Central Europe 7.7% 12.8% CIS 2014 CIS 10.5% GFB6.5% GFB CISGFB 2014 9.5% JTI Winston 0.7ppt 15.0%Camel Sobranie LD4 Rest-of-the-World Rest-of-the-World 0.8% GFB 2.1% JTI No.1 Winston 1.2ppt4.8% MEVIUS MEVIUS 4 Camel2.3% GFB 0.7% 2.4ppt29.0%Camel Winston 20% Rest-of-the-World 3.8% JTIJT 2015 GFB Zandera 2015 Emerging Product 2015 8% 032 JAPAN TOBACCO INC. ANNUAL REPORT 2014

Other Tobacco Products Portfolio Ploom & E-Lites 2014 11JTI ZanderaZandera e-cigarette E-Lites Emerging Products e-cigarette Heat-not-burn e-cigarette Ploom 6 E-Lites OPERATIONS & ANALYSIS Emerging Product Ploom Zerostyle Emerging Product Ploom E-Lites Fine Cut JTI Fine Cut Fine Cut Roll-your-own Make-your-own 2014JTI Fine Cut 11.1% GFB Fine CutWinston Camel LD Benson & Hedges32.7% JTI Fine Cut 20141.6ppt18.8% Amber Leaf Old Holborn JTI Fine Cut 1 2 Fine Cut Shisha JTI 2013 3 20142 1 JT JAPAN TOBACCO INC. ANNUAL REPORT 2014 033

Review of Operations continued 2014 1 12Like-for-Like 6,498 1.0% 2,387 +1.8% JT 2014 1,862 JT 10960% 2014 4 20 20143.6% 1,124 20-1.0% 6,498 1.8% 2,387-3.6% -1.0% +1.8% 1,165 1,124 6,563 6,498 2,346 2,387 2013 1 12 2014 1 12 2013 1 12 2014 1 12 2013 1 12 2014 1 12 034 JAPAN TOBACCO INC. ANNUAL REPORT 2014

JT OPERATIONS & ANALYSIS 2013 2 No.1 1 1978 30 2015 2 33 1969 2015 2 14 1995 8 2 1mg 2015 2 9 1 2 JAPAN TOBACCO INC. ANNUAL REPORT 2014 035

Review of Operations continued MEVIUS 201460.4% 0.1ppt JT MEVIUS % 61.1 61.5 59.6 60.1 60.0 32.8 2013 10 12 JT MEVIUS 33.4 2014 1 3 31.3 2014 4 6 31.7 31.9 2014 7 9 2014 10 12 2014 MEVIUS 2015 2015 4 MEVIUS JT 036 JAPAN TOBACCO INC. ANNUAL REPORT 2014

JT OPERATIONS & ANALYSIS JAPAN TOBACCO INC. ANNUAL REPORT 2014 037

Review of Operations continued 2014 1 12Like-for-Like 658 +76 73 +63 JAKJTE-052 LEO Pharma ElvitegravirHIV Vitekta E/C/F/TAF Trametinib Mekinist dabrafenib 250mg TO-203 2015 1 Stribild 76 63 +76 +63 582 658 137 73 2013 1 12 2014 1 12 2013 1 12 2014 1 12 038 JAPAN TOBACCO INC. ANNUAL REPORT 2014

MR OPERATIONS & ANALYSIS MR MR MR 499 MR MR ISO14001 JAPAN TOBACCO INC. ANNUAL REPORT 2014 039

Review of Operations continued 2015 2 5 JTK-303 elvitegravir / cobicistat/ emtricitabine/ tenofovir alafenamide HIV HIV 2 JTT-851 2 GPR40 JTZ-951 HIF-PHD HIF-PHD JTE-051 ITK T JTE-052 JAK JAK JTE-151 ROR Th17ROR JTE-350* JTT-251 2 PDHK PDH JTT-252 2 SGLT1 SGLT1 JTK-351 HIV HIV * elvitegravir JTK-303 Gilead Sciences HIV HIV elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide trametinib GlaxoSmithKline * MEK dabrafenib MEK Phase 3 ICOS MedImmune ICOS T ICOS JTE-052 LEO Pharma JAK JAK * 2015 3 2GlaxoSmithKilneNovartis 040 JAPAN TOBACCO INC. ANNUAL REPORT 2014

Phase 1 Phase 2 Phase 3 Phase 2 Phase 2 JTK-303 elvitegravir 3 Gilead Sciences OPERATIONS & ANALYSIS Phase 2 Phase 1 Phase 1 Phase 1 Phase 1 Phase 1 ALK Phase1 Phase1 JAPAN TOBACCO INC. ANNUAL REPORT 2014 041

Review of Operations continued 2014 1 12Like-for-Like 1,612 +40 14 +8 2010 * 40 8 * +40 +8 1,572 1,612 14 6 2013 1 12 2014 1 12 2013 1 12 2014 1 12 042 JAPAN TOBACCO INC. ANNUAL REPORT 2014

OPERATIONS & ANALYSIS HACCPISO22000 ISO22000 HACCP 30 ISO22000 JAPAN TOBACCO INC. ANNUAL REPORT 2014 043

Review of Operations continued 2014 1 12Like-for-Like 1,813 25 5 +16 16 25 +16 5 1,838 1,813 21 2013 1 12 2014 1 12 2013 1 12 2014 1 12 2015 2 4 2015 2 4JT JT JT 2015 9 1988 4SJT JT 2015 9JT * 2014 12 2015 12 044 JAPAN TOBACCO INC. ANNUAL REPORT 2014

JT Group and Sustainability JT OPERATIONS & ANALYSIS JT4S 4 4 4S 4S JT JT FY2014 http://www.jti.co.jp/csr/report/index.html JT Group and Sustainability How we do business Our People Responsible Supply Chain Environment Product, Responsibility and Consumer Impact The Bigger Picture JAPAN TOBACCO INC. ANNUAL REPORT 2014 045

Risk Factors JT * CIS * 2015 2 JT 1. JT 046 JAPAN TOBACCO INC. ANNUAL REPORT 2014

2. JT 2007 JT JT International Holding B.V. JT International S.A. EU26 EU 2009 EU 15 5 5010 15 2010JT JTI Macdonald Corp. 3. OPERATIONS & ANALYSIS JT JAPAN TOBACCO INC. ANNUAL REPORT 2014 047

Risk Factors continued 4. 5. JT 6. RJR 2014 12 31 19 149 048 JAPAN TOBACCO INC. ANNUAL REPORT 2014

7. JT OPERATIONS & ANALYSIS JT JT 8. JT JT JT International Holding B.V. JAPAN TOBACCO INC. ANNUAL REPORT 2014 049

Corporate Governance 2000 2000 2001 2001* 2006 2012 200020082011 * 2014 6 30 8 2 JT 4 2 5 3 5 2 2 050 JAPAN TOBACCO INC. ANNUAL REPORT 2014

3 31 3092 31 32 31 3 2011 12 2 * 2023 3 31 * OPERATIONS & ANALYSIS JAPAN TOBACCO INC. ANNUAL REPORT 2014 051

Corporate Governance continued * 1 3 1 2014 11 1951 3 21 2014 6 1 9 500 2014 82 97% 98% 1974 4 2006 10 2007 7 2008 7 2009 7 2010 7 2010 12 2012 12 2014 6 052 JAPAN TOBACCO INC. ANNUAL REPORT 2014

* * * OPERATIONS & ANALYSIS 1957 4 15 1956 1 11 1959 5 22 2014 6 1 9 2014 6 1 9 2014 6 1 9 24,400 23,800 9,900 1981 4 1980 4 1983 4 2001 6 2001 7 2000 4 2003 6 2004 6 2006 6 2007 6 2007 7 & 2009 6 2012 6 2004 6 2004 7 2005 6 2006 6 JT International S.A. Executive Vice President 2011 6 2011 6 2014 6 2002 6 2004 6 2006 6 2009 6 2010 5 2011 1 2012 6 JAPAN TOBACCO INC. ANNUAL REPORT 2014 053

Corporate Governance continued * * 1960 8 25 2014 6 1 9 15,500 1958 1 22 2014 6 1 9 12,100 1985 4 2005 6 2007 6 2008 5 2008 6 2008 7 2009 7 2010 6 2012 6 1980 4 2005 7 2006 1 2008 6 2009 10 2010 5 2010 6 2010 7 2010 8 2012 6 054 JAPAN TOBACCO INC. ANNUAL REPORT 2014

* 1943 9 15 2014 6 1 9 0 1951 4 25 2014 6 1 9 0 OPERATIONS & ANALYSIS 1966 4 1994 6 1998 4 2001 4 2001 6 2007 6 2012 6 2013 6 1995 9 2003 1 2004 4 2005 3 2006 11 2010 6 2012 6 2013 6 LIXIL JAPAN TOBACCO INC. ANNUAL REPORT 2014 055

Corporate Governance continued 4 2 42 2014 100% 1957 11 23 2015 3 4 4,800 1981 4 2004 7 2005 7 2005 9 JT International Holding B.V. Vice President 2009 7 2010 7 2012 6 056 JAPAN TOBACCO INC. ANNUAL REPORT 2014

OPERATIONS & ANALYSIS 1953 12 19 1944 12 3 1947 6 17 2015 3 4 2015 3 4 2015 3 4 0 700 0 1976 4 1968 4 1970 4 2000 7 1995 6 1972 4 2002 7 2000 5 2001 5 2004 7 2003 6 2002 1 2007 4 2008 1 2004 6 2008 1 2011 1 2006 6 2009 8 2011 4 2007 7 2010 3 2011 6 2008 7 2010 10 2010 6 2010 11 2010 12 2013 6 2011 3 2011 4 2013 6 2014 6 2015 3 JAPAN TOBACCO INC. ANNUAL REPORT 2014 057

Corporate Governance continued 2 2 4 1. 2. 3. 4. 5. 6. 7. 8. 9. 28 10. 1 28 2 31 2 058 JAPAN TOBACCO INC. ANNUAL REPORT 2014

OPERATIONS & ANALYSIS 150 JAPAN TOBACCO INC. ANNUAL REPORT 2014 059

Corporate Governance continued JT JT JT 2014 2 060 JAPAN TOBACCO INC. ANNUAL REPORT 2014

OPERATIONS & ANALYSIS JT46 JAPAN TOBACCO INC. ANNUAL REPORT 2014 061

Corporate Governance continued 4 2 2 2014 2 3 2007 8 7 22 2007 6 8 71 9 800 2 062 JAPAN TOBACCO INC. ANNUAL REPORT 2014

2014 12 31 1 2 423 235 102 86 8 54 54 2 41 41 4 517 329 102 86 14 1. 2. 2014 12 31 OPERATIONS & ANALYSIS 2014 12 311 JT 56 34 21 111 2014 12 31 2014 9 19 6 19 35,600 33,20068,800 1200 JAPAN TOBACCO INC. ANNUAL REPORT 2014 063